Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19

Nina Ekström, Tuija M. Leino, Aapo Juutinen, Toni Lehtonen, Anu Haveri, Oona Liedes, Saimi Vara, Heini Salo, Arto A. Palmu, Hanna Nohynek, Timi Martelius, Merit Melin
doi: https://doi.org/10.1101/2023.12.21.23300374

Article Information

doi 
https://doi.org/10.1101/2023.12.21.23300374
History 
  • December 24, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Nina Ekström1,*,
  2. Tuija M. Leino1,
  3. Aapo Juutinen1,
  4. Toni Lehtonen2,
  5. Anu Haveri1,
  6. Oona Liedes1,
  7. Saimi Vara1,
  8. Heini Salo1,
  9. Arto A. Palmu3,
  10. Hanna Nohynek1,
  11. Timi Martelius4 and
  12. Merit Melin1
  1. 1Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
  2. 2Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
  3. 3Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Tampere, Finland Current affiliation: FVR – Finnish Vaccine Research, Tampere, Finland
  4. 4Inflammation Center/Infectious Diseases, Helsinki University Hospital, Helsinki
  1. ↵*Corresponding author; email: nina.ekstrom{at}thl.fi
Back to top
Posted December 24, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Hybrid immunity improves the immune response after fourth Covid-19 vaccine dose in individuals with medical conditions predisposing to severe Covid-19
Nina Ekström, Tuija M. Leino, Aapo Juutinen, Toni Lehtonen, Anu Haveri, Oona Liedes, Saimi Vara, Heini Salo, Arto A. Palmu, Hanna Nohynek, Timi Martelius, Merit Melin
medRxiv 2023.12.21.23300374; doi: https://doi.org/10.1101/2023.12.21.23300374
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area